Figure 3From: Ranibizumab for macular edema secondary to retinal vein occlusion: a meta-analysis of dose effects and comparison with no anti-VEGF treatmentForest plot depicting the meta-analysis for the proportion of patients who loss ≥ 15 ETDRS letters. RR = risk ratio; CI = confidence interval; IVR = intravitreal ranibizumab; VEGF = Vascular endothelial growth factor.Back to article page